Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

Rhea-AI Summary

Deciphera Pharmaceuticals (NASDAQ: DCPH) has announced that Steve Hoerter, President and CEO, will participate in fireside chats at two investor conferences. The Jefferies Virtual Healthcare Conference is set for June 3, 2021, at 1:30 PM ET, and the JMP Securities Life Sciences Conference will follow on June 16, 2021, at 4:00 PM ET. Live webcasts of these events will be accessible on the Company’s Investors page, with replays available for 90 days.

Deciphera specializes in developing new medicines for cancer, utilizing its proprietary kinase inhibitor platform.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in fireside chats at the following investor conferences:

• Jefferies Virtual Healthcare Conference on June 3, 2021 at 1:30 PM ET
• JMP Securities Life Sciences Conference on June 16, 2021 at 4:00 PM ET

A live webcast of both events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay of both webcasts will be archived on the Company’s website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK^® is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumors. For more information, visit https://www.deciphera.com/ or follow us on LinkedIn and Twitter (@Deciphera).

View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005257/en/

FAQ

When will Deciphera Pharmaceuticals participate in investor conferences?

Deciphera Pharmaceuticals will participate in the Jefferies Virtual Healthcare Conference on June 3, 2021, at 1:30 PM ET and the JMP Securities Life Sciences Conference on June 16, 2021, at 4:00 PM ET.

How can I watch the Deciphera Pharmaceuticals investor conference webcasts?

You can watch the live webcasts of Deciphera Pharmaceuticals' investor conferences on the Company's 'Events and Presentations' page found in the Investors section of their website.

How long will the replays of the Deciphera Pharmaceuticals webcasts be available?

Replays of the webcasts will be archived on Deciphera Pharmaceuticals' website for 90 days following the presentations.

What is Deciphera Pharmaceuticals known for?

Deciphera Pharmaceuticals is known for discovering and developing innovative medicines for cancer, including its FDA-approved treatment QINLOCK® for gastrointestinal stromal tumors.